share_log

NYSE to Commence Delisting Proceedings Against Cano Health, Inc. (CANO)

NYSE to Commence Delisting Proceedings Against Cano Health, Inc. (CANO)

紐約證券交易所將啓動對Cano Health, Inc.(CANO)的退市程序
Businesswire ·  02/06 05:15

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange LLC ("NYSE" or "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common stock of Cano Health, Inc. (the "Company") — ticker symbol CANO — from the NYSE. Trading in the Company's Class A common stock will be suspended immediately.

紐約--(美國商業資訊)--紐約證券交易所有限責任公司(“紐約證券交易所” 或 “交易所”)今天宣佈,紐約證券交易所監管機構的工作人員已決定啓動程序,將Cano Health, Inc.(“公司”)的A類普通股(股票代碼爲CANO)從紐約證券交易所退市。公司A類普通股的交易將立即暫停。

NYSE Regulation reached its decision that the Company is no longer suitable for listing pursuant to Listed Company Manual Section 802.01D after the Company's February 4, 2024 press release that the Company has initiated prearranged voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware. In reaching its delisting determination, NYSE Regulation noted that the Restructuring Support Agreement that Company entered into with its lenders provides for the conversion of nearly $1 billion in secured debt to a combination of new debt and full equity ownership in the reorganized company.

紐約證券交易所監管機構作出決定,根據《上市公司手冊》第802.01D條,該公司不再適合上市,此前該公司於2024年2月4日發佈新聞稿,稱公司已在美國特拉華特區破產法院啓動了預先安排的第11章自願程序。紐約證券交易所監管機構在做出退市決定時指出,該公司與貸款機構簽訂的重組支持協議規定將近10億美元的有擔保債務轉換爲重組後公司的新債務和全額股權的組合。

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company's Class A common stock upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff's decision.

公司有權要求交易所董事會委員會對這一決定進行審查。在完成所有適用程序(包括公司對紐約證券交易所監管工作人員的決定提出的任何上訴)後,紐約證券交易所將向美國證券交易委員會申請將公司的A類普通股除名。


Contacts
聯繫人

Company Contacts:
Investor Contact
Cano Health IR
investors@canohealth.com

公司聯繫人:
投資者聯繫人
卡諾健康紅外線
investors@canohealth.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

紐約證券交易所聯繫人:
紐約證券交易所通訊
PublicRelations-NYSE@ice.com

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論